期刊文献+

同种异体骨髓间充质干细胞保护大鼠肝脏热缺血再灌注损伤的研究 被引量:4

Protective Effect of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells Transplantation on Hepatic Warm Ischemia Reperfusion Injury in Rats
原文传递
导出
摘要 目的探讨同种异体骨髓间充质干细胞(BM-MSCs)对大鼠肝脏热缺血再灌注损伤的保护作用。方法取10只健康Wistar大鼠骨髓,体外分离、培养间充质干细胞,对其进行生物学鉴定,并对门静脉途径移植入肝脏的间充质干细胞行4,6-联脒-2-苯基吲哚(DAPI)染色示踪。建立大鼠70%肝脏缺血再灌注损伤模型,将32只雄性Wistar大鼠随机分成假手术组(Sham组)、缺血再灌注组(I/R组)、维生素C治疗组(VC组)及BM-MSCs组,每组8只,分别于再灌注24 h后取材,检测血清天门冬氨酸氨基转移酶(AST)和丙氨酸氨基转移酶(ALT)水平,肝脏组织总超氧化物歧化酶(SOD)和丙二醛(MDA)含量,并对肝脏组织行HE染色观察病理学改变,TUNEL法检测肝脏凋亡指数(AI)。结果体外分离的BM-MSCs生长稳定,增殖旺盛,表达CD29及CD44,不表达CD34及CD45;大鼠肝脏缺血再灌注损伤模型稳定,在肝脏组织切片内见间充质干细胞定植,多位于肝小叶中央静脉周围。VC组和BM-MSCs组的AST、ALT、MDA和AI均较I/R组低(P<0.05),SOD均较I/R组高(P<0.05);BM-MSCs组的AST、ALT、MDA和AI均低于VC组(P<0.05),SOD高于VC组(P<0.05)。结论 BM-MSCs可通过减轻氧化应激损伤和抑制肝细胞凋亡,来保护大鼠肝脏热缺血再灌注损伤。 Objective To explore repair role of allogeneic bone marrow mesenchymal stem cells(BM-MSCs) transplantation on treating hepatic ischemia reperfusion injury(HIRI) in rats.Methods Ten rats were executed to get BM-MSCs,then BM-MSCs were cultured in vitro and dyed by 4,6-diamidino-2-phenylindole(DAPI).Models of 70% hepatic ischemia reperfusion injury were eatablished.Thirty two rats were randomly divided into sham operation group(Sham group),ischemia reperfusion group(I/R group),Vitamin C group(VC group),and BM-MSCs group.Serum samples were analyzed for ALT and AST,and hepatic tissue were for superoxide dismutase(SOD) and malondialdehyde(MDA).Liver sections were stain with hematoxylin and eosin(HE) for histological analysis,TUNEL staining was applied to detect hepatic apoptosis.Serum and tissues were both collected at 24 h after reperfusion.Results The isolated BM-MSCs maintained vigorous growth in vitro.Specific markers for MSCs antigens CD29 and CD44 were detected by flow cytometry,but antigens CD34 and CD45 were not be detected.Models of HIRI were stable,and BM-MSCs were detected around the periportal area by DAPI staining.Compared with I/R group,levels of ALT,AST,MDA,and AI in the VC group and BM-MSCs group decreased at 24 h after reperfusion(P0.05),meanwhile SOD level increased(P0.05).Compared with VC group,levels of ALT,AST,MDA,and AI in the BM-MSC group decreased at 24 h after reperfusion(P0.05),meanwhile SOD level increased(P0.05).Conclusion BM-MSCs could protect HIRI by alleviating oxidative stress and inhibiting cellular apoptosis.
出处 《中国普外基础与临床杂志》 CAS 2013年第1期60-65,共6页 Chinese Journal of Bases and Clinics In General Surgery
关键词 骨髓间充质干细胞 肝脏缺血再灌注损伤 氧化应激 凋亡 干细胞治疗 Bone marrow derived mesenchymal stem cells Hepatic ischemia reperfusion injury Oxidative stress Apoptosis Stem cell therapy
  • 相关文献

参考文献25

  • 1Glantzounis GK,Salacinski H J,Yang W. The contemporary role of antioxidant therapy in attenuating liver ischemiareperfusion injury:a review[J].Liver Transplantation,2005,(09):1031-1047.
  • 2Coriat R,Leconte M,Kavian N. Mangafodipir protects against hepatic ischemia-reperfusion injury in mice[J].PLoS ONE,2011,(11):e27005.
  • 3Loffredo FS,Steinhauser ML,Gannon J. Bone marrowderived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair[J].Cell Stem Cell,2011,(04):389-398.
  • 4Gatti S,Bruno S,Deregibus MC. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemiareperfusion-induced acute and chronic kidney injury[J].Nephrology Dialysis Transplantation,2011,(05):1474-1483.
  • 5Liu L,Cao JX,Sun B. Mesenchymal stem cells inhibition of chronic ethanol-induced oxidative damage via upregulation of phosphatidylinositol-3-kinase/Akt and modulation of extracellular signal-regulated kinase 1/2 activation in PC12 cells and neurons[J].Neuroscience,2010,(04):1115-1124.
  • 6高峰,李国良,林雨佳,仇公才,吴德全.骨髓间充质干细胞移植途径对胰岛移植物免疫排斥反应的影响[J].中国普通外科杂志,2012,21(9):1080-1085. 被引量:5
  • 7石臣磊,秦华东,丁超.依达拉奉对肝缺血再灌注损伤逆转作用的研究[J].中国普外基础与临床杂志,2011,18(8):887-889. 被引量:6
  • 8Hu, Yan-Hua,Wu, De-Quan,Gao, Feng,Li, Guo-Dong,Yao, Lei,Zhang, Xin-Chen.A secretory function of human insulin-producing cells in vivo[J].Hepatobiliary & Pancreatic Diseases International,2009,8(3):255-260. 被引量:3
  • 9Hassan-Khabbar S,Vamy M,Cottart CH. Protective effect of post-ischemic treatment with trans-resveratrol on cytokine production and neutrophil recruitment by rat liver[J].Biochimie,2010,(04):405-410.
  • 10Jaeschke H. Reactive oxygen and ischemia/reperfusion injury of the liver[J].Chemico-Biological Interactions,1991,(02):115-136.

二级参考文献45

共引文献19

同被引文献46

  • 1Yin Yin Ooi,Zul'atfi Rahmat,Shinsmon Jose,Rajesh Ramasamy,Sharmili Vidyadaran,.Immunophenotype and differentiation capacity of bone marrow-derived mesenchymal stem cells from CBA/Ca,ICR and Balb/c mice[J].World Journal of Stem Cells,2013,5(1):34-42. 被引量:4
  • 2郭丽,尹飞,凌翎,李鹏,呼和塔娜,陈强,范洪学.大鼠骨髓间充质干细胞向软骨、脂肪和神经元样细胞分化的研究[J].吉林大学学报(医学版),2004,30(6):846-849. 被引量:1
  • 3唐艳娟,李毅,陈槐卿,吴巧凤,尹光福,周大利.犬骨髓间充质干细胞的生长特点和在诱骨条件下的成骨特性[J].生物医学工程学杂志,2006,23(1):142-146. 被引量:4
  • 4Fan C, Zwacka RM, Engelhardt JF. Therapeutic approaches for ischemia/reperfusion injury in the liver [J]. J Mol Med (Berl), 1999, 77(8): 577-592.
  • 5Kanazawa H, Fujimoto Y, Teratani T, et al. Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model IJJ. PLoS One, 2011, 6(4): e19195.
  • 6Pittenger MF, Mackay AM, Beck SC, et al. Multilineage poten- tial of adult human mesenchymal stem cells [J]. Science, 1999, 284(5411): 143-147.
  • 7Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement [J]. Cytotherapy, 2006, 8(4): 315-317.
  • 8Casiraghi F, Azzollini N, Cassis P, et al. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semial-logeneic heart transplant through the generation of regulatory T cells [J]. J Immunol, 2008, 181(6): 3933-3946.
  • 9Chabannes D, Hill M, Merieau E, et al. A role for heme oxyge- nase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells [J]. Blood, 2007, 110(10): 3691-3694.
  • 10Popp FC, Eggenhofer E, Renner P, et al. Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate [J]. Transpl lmmunol, 2008, 20(1-2): 55-60.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部